Peripartum cardiomyopathy management-multidisciplinary approach 2011-2013 at Care Institute of Medical Sciences

Pratibha Devabhaktuni, Sridevi Chennapragada, Sushma Manchala, Rajeev Menon, Neelkanth Patil, Somaraju Bhupatiraju


Background: Peripartum cardiomyopathy (PPCM) is one of the rare causes of heart failure in pregnant women. It occurs in late pregnancy or up to 5 months post-partum. It is associated with high mortality and morbidity but with chances of full recovery. This paper discusses the treatment of peripartum cardiomyopathy, Peripartum cardiomyopathy management -multidisciplinary approach. 2011-2013 at CIMS.

Methods: This is an observational study conducted at CARE institute of medical sciences, CIMS, during 2011-2013 years. Women fulfilling the criteria for the diagnosis of PPCM were included in the study. In this study we have analysed the obstetric intervention, the duration of ICU stay, hospital stay, maternal and perinatal outcomes. The cardiac drugs to manage each individual case suited to her condition have been mentioned.

Results: Six cases were diagnosed to have PPCM in pregnancy when there was sudden onset of shortness of breath, cough, and palpitations. Four cases had history of PPCM in previous pregnancies and were managed in the current pregnancy. One rare case had features of cardiomyopathy seen in early gestational period, during the first trimester at eight weeks, when she was treated for ectopic gestation. Patients were managed by pregnancy cardiac team. There was no case of maternal mortality.

Conclusions: PPCM is a rare condition. It requires a high index of suspicion and awareness among primary care givers for early diagnosis and prompt management. A pregnancy cardiac team approach benefits this subset of patients. Delayed time of presentation, LVEF and dilated ventricle are factors determining recovery.


Peripartum cardiomyopathy, Pregnancy, Heart disease, Cardiomyopathy, Pregnancy cardiac team

Full Text:



Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunna RM. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053-61.

Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97:1765-8.

The Relationship Between Preeclampsia and Peripartum Cardiomyopathy: A Systematic Review and Meta-Analysis Natalie Bello, MD, Iliana S. Hurtado Rendon, MD, and Zoltan Arany, MD, PhDAm Coll Cardiol. 2013;62(18):1715-23.

Fett JD, Christie LG, Carraway RD. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602-6.

Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Europ Heart J. 2006;27(4):441-6.

Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302-4.

Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120:1013-9.

Krishnamoorthy P, Garg J, Palaniswamy C, Pandey A, Ahmad H, Frishman WH, et al. Epidemiology and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample. J Cardiovasc Med. 2016;17(10):756-61.

Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (National Institutes of Health) workshop recommendations and review. J Am Medic Assoc. 2000;283(9):1183-8.

Sliwa K, Hilfiker‐Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Europ J Hea Fail. 2010;12(8):767-78.

Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predic- tors, and outcomes. Obstet Gynecol. 2011;118:583-91.

Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Temporal trends in inci- dence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3:e001056.

Prasad GS, Bhupali A, Prasad S, Patil AN, Deka Y. Peripartum cardiomyopathy–case series. Ind Hea J. 2014;66(2):223-6.

ESC Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Europ Hea J. 2011;32:3147-97.

Lewey J, Levine LD, Elovitz MA, Irizarry O, Arany Z. The impor- tance of early diagnosis in peripartum cardiomyopathy. Hypertension. 2019;74.

Multidisciplinary management of peripartum cardiomyopathy during repeat cesarean delivery: a case report Janice Shannon-Cain 1, Eric Hunt, Brian S Cain AANA J. 2008;76(6):443-7.

Fett JD. Validation of a self-test for early diagnosis of heart failure in peripartum cardiomyopathy. Crit Pathw Cardiol. 2011;10(1):44-5.

ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines 2013;62:16.

Ramachandran R, Rewari V, Trikha A. Anaesthetic management of patients with Peripartum Cardiomyopathy. J Obstet Anaesth Crit Care. 2011:5-12

Dinic V, Markovic D, Savic N, Kutlesic M, Jankovic RJ. Peripartum cardiomyopathy in intensive care unit: an update. Front Medic. 2015;2:82.

McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905-14.

Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail. 2012;14(8):895-901.

Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.

Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199(4):415-e1.

Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050-5.

Wu VC, Chen TH, Yeh JK, Wu M, Lu CH, Chen SW, et al. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia. Medicine. 2017;96(43).